| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $80.8M | +25.1% |
| SG&A Expense | $23.8M | +25.4% |
| Operating Income | -$104.6M | -25.2% |
| Income Tax | $232K | — |
| Net Income | -$89.0M | -24.4% |
| EPS (Basic) | -$1.89 | +6.0% |
| EPS (Diluted) | -$1.89 | +6.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.1M | +23.9% |
| Short-term Investments | $189.3M | +23.7% |
| Current Assets | $318.1M | +19.5% |
| Total Assets | $325.8M | +19.8% |
| Current Liabilities | $15.9M | -38.5% |
| Total Liabilities | $15.9M | -38.7% |
| Stockholders' Equity | $309.8M | +26.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.2M | -19.5% |
| Investing Cash Flow | -$36.0M | +75.7% |
| Financing Cash Flow | $133.2M | -43.2% |